Ann: Prana provides regulatory update for PBT2-PBT.AX, page-75

I know you may never get that point properly. It is not bad for you to remain optimistic and keep losing money. I won't believe PBT is a successful company until someday one candidate in its pipeline gets approval. If we assume the odds for it get through each checkpoint are fifty percent, the possibility for its final approval is definitely lower than most gambling games. Although it is based on science, its science finally needs a successful drug to prove itself as a good science. That is why a confirmative clinical trial is needed. Then I don't like this management team, but I would like to buy this stock when it is ugly low. I would like to dump it when it spikes. I won't worry about whether I can buy it back or not. It has never disappointed me to date. There is always high and low. The market is always full of opportunities. Here you need to make money by trading. Keyboard finghting is useless. As for this stock, one thing is for sure since April 2014. You know it.